title: Bone marrow transplantation in miniature swine. III. Graft-versus-host disease and the effect of T cell depletion of marrow.
abstract: Graft-versus-host disease (GVHD) has been evaluated in partially inbred miniature swine in order to study this complication of allogeneic bone marrow transplantation (BMT) in a major histocompatibility complex (MHC) genetically defined large animal model. Bone marrow from MHC homozygous ("parental") swine was injected into irradiated (900 rads total-body irradiation) MHC heterozygous ("F1") swine that shared one haplotype with the donor. All 18 animals successfully engrafted with donor bone marrow, and 17 of these developed skin rash of varying intensity depending on the extent of T cell depletion of infused marrow. Of 18 animals, 8 received undepleted bone marrow from exsanguinated donors and 2 also received additional peripheral blood lymphocytes (PBL) as a source of mature T cells. All 8 showed a moderate-to-severe rash, and the 2 pigs that received additional donor PBL developed the most severe rash. The cutaneous eruption seen in this model clinically, histologically, and immunologically resembled human GVHD. Two protocols of T cell depletion of donor bone marrow by antiporcine T cell monoclonal antibodies plus complement were tested for their effect on development of GVHD. The combination of two monoclonal antibodies, 74-12-4 (PT4) and 76-2-11 (PT8), had a marginal effect on the subsequent development of cutaneous manifestations of GVHD. However, treatment of the donor marrow by a combination of three monoclonal antibodies--PT4, PT8, and MSA4 (PT11)--effectively decreased the severity of the GVHD skin rash. These results indicate that (1) the GVHD associated with allogeneic bone marrow transplantation in swine is dependent on T cells in the marrow; (2) effective T cell depletion of donor marrow by monoclonal antibodies and complement does not prevent engraftment; and (3) this swine GVHD model, which allows study with F1 and homozygous parental combinations in an MHC genetically defined large animal, is particularly useful for the understanding of GVHD pathogenesis, prevention, and treatment.
authors.affiliation: Immunology Branch, National Cancer Institute, Bethesda, MD 20892.
authors.forename: K
authors.initials: K
authors.lastname: Sakamoto
authors.forename: D H
authors.initials: DH
authors.lastname: Sachs
authors.forename: S
authors.initials: S
authors.lastname: Shimada
authors.forename: F A
authors.initials: FA
authors.lastname: Popitz-Bergez
authors.forename: L R
authors.initials: LR
authors.lastname: Pennington
authors.forename: M D
authors.initials: MD
authors.lastname: Pescovitz
authors.forename: M A
authors.initials: MA
authors.lastname: McDonough
authors.forename: T J
authors.initials: TJ
authors.lastname: MacVittie
authors.forename: S I
authors.initials: SI
authors.lastname: Katz
authors.forename: R E
authors.initials: RE
authors.lastname: Gress
mesh_terms: D000818:Animals; D016026:Bone Marrow Transplantation; D006086:Graft vs Host Disease / Q000276:immunology* / Q000517:prevention & control; D007108:Immune Tolerance; D008285:Major Histocompatibility Complex; D012867:Skin / Q000473:pathology; D016038:Skin Transplantation; D013552:Swine / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology*; D013997:Time Factors